Interaction between sex hormones and WNT/β-catenin signal transduction in endometrial physiology and disease

Molecular and Cellular Endocrinology

Volumn 358, Issue 2, 2012, Pages 176-184

  van der Horst, Paul H ^a   Wang, Yongyi ^a   van der Zee, Marten ^a   Burger, Curt W ^a   Blok, Leen J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Endometrium; Estrogen; M llerian duct; Myometrium; Progesterone; Wnt catenin

Indexed keywords

BETA CATENIN; DICKKOPF 1 PROTEIN; ESTROGEN; PROGESTERONE; SEX HORMONE; TRANSCRIPTION FACTOR FKHR; WNT PROTEIN; WNT4 PROTEIN; WNT5A PROTEIN; WNT6 PROTEIN; WNT7A PROTEIN; WNT9B PROTEIN;

ADENOMYOSIS; CARCINOGENESIS; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; DECIDUALIZATION; EMBRYO DEVELOPMENT; ENDOMETRIOSIS; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; EPITHELIAL MESENCHYMAL TRANSITION; HORMONAL REGULATION; HUMAN; MENSTRUAL CYCLE; MOLECULAR INTERACTION; MUELLERIAN DUCT; MYOMETRIUM; NIDATION; NONHUMAN; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; PROLIFERATIVE PHASE; REVIEW; SECRETORY PHASE; SIGNAL TRANSDUCTION; TROPHOBLAST; WNT BETA CATENIN SIGNALING PATHWAY;

ANIMALS; EMBRYO IMPLANTATION; ENDOMETRIUM; FEMALE; GONADAL STEROID HORMONES; HUMANS; PLACENTA; PREGNANCY; UTERINE DISEASES; WNT SIGNALING PATHWAY;

EID: 84861532137     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.06.010     Document Type: Review

References (86)

1. Amant F., Moerman P., Neven P., Timmerman D., Van Limbergen E., Vergote I. Endometrial cancer. Lancet 2005, 366:491-505.
2. Arango N.A., Szotek P.P., Manganaro T.F., Oliva E., Donahoe P.K., Teixeira J. Conditional deletion of beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium. Dev. Biol. 2005, 288:276-283.
3. Arango N.A., Kobayashi A., Wang Y., Jamin S.P., Lee H.H., Orvis G.D., Behringer R.R. A mesenchymal perspective of Mullerian duct differentiation and regression in Amhr2-lacZ mice. Mol. Reprod. Dev. 2008, 75:1154-1162.
4. Behrens J., Jerchow B.A., Wurtele M., Grimm J., Asbrand C., Wirtz R., Kuhl M., Wedlich D., Birchmeier W. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 1998, 280:596-599.
5. Bulun S.E., Cheng Y.H., Pavone M.E., Xue Q., Attar E., Trukhacheva E., Tokunaga H., Utsunomiya H., Yin P., Luo X., Lin Z., Imir G., Thung S., Su E.J., Kim J.J. Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. Semin. Reprod. Med. 2010, 28:36-43.
6. Bulun S.E., Cheng Y.H., Pavone M.E., Yin P., Imir G., Utsunomiya H., Thung S., Xue Q., Marsh E.E., Tokunaga H., Ishikawa H., Kurita T., Su E.J. 17Beta-hydroxysteroid dehydrogenase-2 deficiency and progesterone resistance in endometriosis. Semin. Reprod. Med. 2010, 28:44-50.
7. Burney R.O., Talbi S., Hamilton A.E., Vo K.C., Nyegaard M., Nezhat C.R., Lessey B.A., Giudice L.C. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology 2007, 148:3814-3826.
8. Carroll T.J., Park J.S., Hayashi S., Majumdar A., McMahon A.P. Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Dev. Cell 2005, 9:283-292.
9. Carson D.D., Bagchi I., Dey S.K., Enders A.C., Fazleabas A.T., Lessey B.A., Yoshinaga K. Embryo implantation. Dev. Biol. 2000, 223:217-237.
10. Catalano R.D., Critchley H.O., Heikinheimo O., Baird D.T., Hapangama D., Sherwin J.R.A., Charnock-Jones D.S., Smith S.K., Sharkey A.M. Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium. Mol. Hum. Reprod. 2007, 13:641-654.
11. Clevers H. Wnt/[beta]-catenin signaling in development and disease. Cell 2006, 127:469-480.
12. Cloke B., Huhtinen K., Fusi L., Kajihara T., Yliheikkila M., Ho K.-K., Teklenburg G., Lavery S., Jones M.C., Trew G., Kim J.J., Lam E.W.-F., Cartwright J.E., Poutanen M., Brosens J.J. The androgen and progesterone receptors regulate distinct gene networks and cellular functions in decidualizing endometrium. Endocrinology 2008, 149:4462-4474.
13. Daniels D.L., Weis W.I. Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat. Struct. Mol. Biol. 2005, 12:364-371.
14. Deutscher E., Hung-Chang Yao H. Essential roles of mesenchyme-derived beta-catenin in mouse Mullerian duct morphogenesis. Dev. Biol. 2007, 307:227-236.
15. Dey S.K., Lim H., Das S.K., Reese J., Paria B.C., Daikoku T., Wang H. Molecular cues to implantation. Endocr. Rev. 2004, 25:341-373.
16. Franco, H.L., Dai, D., Lee, K.Y., Rubel, C.A., Roop, D., Boerboom, D., Jeong, J.W., Lydon, J.P., Bagchi, I.C., Bagchi, M.K. and Demayo, F.J. (2010) WNT4 is a key regulator of normal postnatal uterine development and progesterone signaling during embryo implantation and decidualization in the mouse. FASEB J.
17. Gaetje R., Holtrich U., Karn T., Cikrit E., Engels K., Rody A., Kaufmann M. Characterization of WNT7A expression in human endometrium and endometriotic lesions. Fertility and Sterility 2007, 88:1534-1540.
18. Galceran J., Farinas I., Depew M.J., Clevers H., Grosschedl R. Wnt3a-/-like phenotype and limb deficiency in Lef1(-/-)Tcf1(-/-) mice. Genes Dev. 1999, 13:709-717.
19. Gellersen B., Brosens I.A., Brosens J.J. Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives. Semin. Reprod. Med. 2007, 25:445-453.
20. Giudice L.C., Kao L.C. Endometriosis. Lancet 2004, 364:1789-1799.
21. Guioli S., Sekido R., Lovell-Badge R. The origin of the Mullerian duct in chick and mouse. Dev. Biol. 2007, 302:389-398.
22. Gunin A.G., Emelianov V.U., Mironkin I.U., Morozov M.P., Tolmachev A.S. Lithium treatment enhances estradiol-induced proliferation and hyperplasia formation in the uterus of mice. Eur. J. Obstet. Gynecol. Reprod. Biol. 2004, 114:83-91.
23. Hanifi-Moghaddam P., Boers-Sijmons B., Klaassens A.H., van Wijk F.H., den Bakker M.A., Ott M.C., Shipley G.L., Verheul H.A., Kloosterboer H.J., Burger C.W., Blok L.J. Molecular analysis of human endometrium: short-term tibolone signaling differs significantly from estrogen and estrogen + progestagen signaling. J. Mol. Med. 2007, 85:471-480.
24. Hayashi K., Erikson D.W., Tilford S.A., Bany B.M., Maclean J.A., Rucker E.B., Johnson G.A., Spencer T.E. Wnt Genes in the Mouse Uterus: Potential Regulation of Implantation. Biol. Reprod. 2009, 80:989-1000.
25. Hecht J.L., Mutter G.L. Molecular and pathologic aspects of endometrial carcinogenesis. J. Clin. Oncol. 2006, 24:4783-4791.
26. Hou X., Tan Y., Li M., Dey S.K., Das S.K. Canonical Wnt signaling is critical to estrogen-mediated uterine growth. Mol. Endocrinol. 2004, 18:3035-3049.
27. Huszar M., Pfeifer M., Schirmer U., Kiefel H., Konecny G.E., Ben-Arie A., Edler L., Munch M., Muller-Holzner E., Jerabek-Klestil S., Abdel-Azim S., Marth C., Zeimet A.G., Altevogt P., Fogel M. Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas. J. Pathol. 2010, 220:551-561.
28. Ishikawa T., Tamai Y., Zorn A.M., Yoshida H., Seldin M.F., Nishikawa S., Taketo M.M. Mouse Wnt receptor gene Fzd5 is essential for yolk sac and placental angiogenesis. Development 2001, 128:25-33.
29. Jamin S.P., Arango N.A., Mishina Y., Hanks M.C., Behringer R.R. Requirement of Bmpr1a for Mullerian duct regression during male sexual development. Nat. Genet. 2002, 32:408-410.
30. Jeong J.W., Lee H.S., Franco H.L., Broaddus R.R., Taketo M.M., Tsai S.Y., Lydon J.P., DeMayo F.J. Beta-catenin mediates glandular formation and dysregulation of beta-catenin induces hyperplasia formation in the murine uterus. Oncogene 2009, 28:31-40.
31. Kamino M., Kishida M., Kibe T., Ikoma K., Iijima M., Hirano H., Tokudome M., Chen L., Koriyama C., Yamada K., Arita K., Kishida S. Wnt-5a signaling is correlated with infiltrative activity in human glioma by inducing cellular migration and MMP-2. Cancer Sci. 2011, 102:540-548.
32. Kao L.C., Tulac S., Lobo S., Imani B., Yang J.P., Germeyer A., Osteen K., Taylor R.N., Lessey B.A., Giudice L.C. Global Gene Profiling in Human Endometrium during the Window of Implantation. Endocrinology 2002, 143:2119-2138.
33. Kao L.C., Germeyer A., Tulac S., Lobo S., Yang J.P., Taylor R.N., Osteen K., Lessey B.A., Giudice L.C. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 2003, 144:2870-2881.
34. Katoh M. WNT/PCP signaling pathway and human cancer (review). Oncol Rep 2005, 14:1583-1588.
35. Klemm F., Bleckmann A., Siam L., Chuang H.N., Rietkotter E., Behme D., Schulz M., Schaffrinski M., Schindler S., Trumper L., Kramer F., Beissbarth T., Stadelmann C., Binder C., Pukrop T. {beta}-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis. Carcinogenesis 2011, 32:434-442.
36. Kobayashi A., Shawlot W., Kania A., Behringer R.R. Requirement of Lim1 for female reproductive tract development. Development 2004, 131:539-549.
37. Kohn A.D., Moon R.T. Wnt and calcium signaling: beta-catenin-independent pathways. Cell Calcium 2005, 38:439-446.
38. Konopka B., Janiec-Jankowska A., Czapczak D., Paszko Z., Bidzinski M., Olszewski W., Goluda C. Molecular genetic defects in endometrial carcinomas: microsatellite instability, PTEN and beta-catenin (CTNNB1) genes mutations. J. Cancer Res. Clin. Oncol. 2007, 133:361-371.
39. Kuokkanen S., Chen B., Ojalvo L., Benard L., Santoro N., Pollard J.W. Genomic profiling of microRNAs and messenger RNAs reveals hormonal regulation in microRNA expression in human endometrium. Biol. Reprod. 2010, 82:791-801.
40. Lee K.Y., Jeong J.W., Wang J., Ma L., Martin J.F., Tsai S.Y., Lydon J.P., DeMayo F.J. Bmp2 is critical for the murine uterine decidual response. Mol. Cell Biol. 2007, 27:5468-5478.
41. Li Q., Kannan A., Wang W., DeMayo F.J., Taylor R.N., Bagchi M.K., Bagchi I.C. Bone Morphogenetic Protein 2 Functions via a Conserved Signaling Pathway Involving Wnt4 to Regulate Uterine Decidualization in the Mouse and the Human. J. Biol. Chem. 2007, 282:31725-31732.
42. Marchand, M., Horcajadas, J.A., Esteban, F.J., McElroy, S.L., Fisher, S.J. and Giudice, L.C. (2011) Transcriptomic Signature of Trophoblast Differentiation in a Human Embryonic Stem Cell Model. Biol Reprod.
43. Maruyama T., Yoshimura Y. Molecular and cellular mechanisms for differentiation and regeneration of the uterine endometrium. Endocr. J. 2008, 55:795-810.
44. Mericskay M., Kitajewski J., Sassoon D. Wnt5a is required for proper epithelial-mesenchymal interactions in the uterus. Development 2004, 131:2061-2072.
45. Miller C., Sassoon D.A. Wnt-7a maintains appropriate uterine patterning during the development of the mouse female reproductive tract. Development 1998, 125:3201-3211.
46. Miller C., Pavlova A., Sassoon D.A. Differential expression patterns of Wnt genes in the murine female reproductive tract during development and the estrous cycle. Mech. Dev. 1998, 76:91-99.
47. Mohamed O.A., Dufort D., Clarke H.J. Expression and estradiol regulation of wnt genes in the mouse blastocyst identify a candidate pathway for embryo-maternal signaling at implantation. Biol. Reprod. 2004, 71:417-424.
48. Mohamed O.A., Jonnaert M., Labelle-Dumais C., Kuroda K., Clarke H.J., Dufort D. Uterine Wnt/beta-catenin signaling is required for implantation. Proc. Natl. Acad. Sci. USA 2005, 102:8579-8584.
49. Monkley S.J., Delaney S.J., Pennisi D.J., Christiansen J.H., Wainwright B.J. Targeted disruption of the Wnt2 gene results in placentation defects. Development 1996, 122:3343-3353.
50. Moreno-Bueno G., Hardisson D., Sanchez C., Sarrio D., Cassia R., Garcia-Rostan G., Prat J., Guo M., Herman J.G., Matias-Guiu X., Esteller M., Palacios J. Abnormalities of the APC/beta-catenin pathway in endometrial cancer. Oncogene 2002, 21:7981-7990.
51. Nei H., Saito T., Yamasaki H., Mizumoto H., Ito E., Kudo R. Nuclear localization of β-catenin in normal and carcinogenic endometrium. Mol. Carcinog. 1999, 25:207-218.
52. Norwitz E.R., Schust D.J., Fisher S.J. Implantation and the survival of early pregnancy. N. Engl. J. Med. 2001, 345:1400-1408.
53. Nusse R., Varmus H.E. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 1982, 31:99-109.
54. Orvis G.D., Behringer R.R. Cellular mechanisms of Mullerian duct formation in the mouse. Dev. Biol. 2007, 306:493-504.
55. Parr B.A., McMahon A.P. Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a. Nature 1998, 395:707-710.
56. Parr B.A., Cornish V.A., Cybulsky M.I., McMahon A.P. Wnt7b regulates placental development in mice. Dev. Biol. 2001, 237:324-332.
57. Pijnenborg J.M., Kisters N., van Engeland M., Dunselman G.A., de Haan J., de Goeij A.F., Groothuis P.G. APC, beta-catenin, and E-cadherin and the development of recurrent endometrial carcinoma. Int. J. Gynecol. Cancer 2004, 14:947-956.
58. Pinson K.I., Brennan J., Monkley S., Avery B.J., Skarnes W.C. An LDL-receptor-related protein mediates Wnt signalling in mice. Nature 2000, 407:535-538.
59. Pollheimer J., Loregger T., Sonderegger S., Saleh L., Bauer S., Bilban M., Czerwenka K., Husslein P., Knofler M. Activation of the canonical wingless/T-cell factor signaling pathway promotes invasive differentiation of human trophoblast. Am. J. Pathol. 2006, 168:1134-1147.
60. Polotsky A.J., Zhu L., Santoro N., Pollard J.W. Lithium chloride treatment induces epithelial cell proliferation in xenografted human endometrium. Hum. Reprod. 2009, 24:1960-1967.
61. Saegusa M., Okayasu I. Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation. J. Pathol. 2001, 194:59-67.
62. Sauer B., Henderson N. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc. Natl. Acad. Sci. USA 1988, 85:5166-5170.
63. Schindler A.E. Progestogen deficiency and endometrial cancer risk. Maturitas 2009, 62:334-337.
64. Schmalhofer O., Brabletz S., Brabletz T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev. 2009, 28:151-166.
65. Scholten A.N., Creutzberg C.L., van den Broek L.J., Noordijk E.M., Smit V.T. Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma. J. Pathol. 2003, 201:460-465.
66. Sonderegger S., Husslein H., Leisser C., Knöfler M. Complex expression pattern of wnt ligands and frizzled receptors in human placenta and its trophoblast subtypes. Placenta 2007, 28:S97-S102.
67. Sonderegger S., Pollheimer J., Knöfler M. Wnt signalling in implantation, decidualisation and placental differentiation - review. Placenta 2010, 31:839-847.
68. Sonderegger S., Haslinger P., Sabri A., Leisser C., Otten J.V., Fiala C., Knofler M. Wingless (Wnt)-3A induces trophoblast migration and matrix metalloproteinase-2 secretion through canonical Wnt signaling and protein kinase B/AKT activation. Endocrinology 2010, 151:211-220.
69. Nusse, R. The Wnt Homepage/ http://www.stanford.edu/group/nusselab/cgi-bin/wnt.
70. Stark K., Vainio S., Vassileva G., McMahon A.P. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 1994, 372:679-683.
71. Takano M., Lu Z., Goto T., Fusi L., Higham J., Francis J., Withey A., Hardt J., Cloke B., Stavropoulou A.V., Ishihara O., Lam E.W.-F., Unterman T.G., Brosens J.J., Kim J.J. Transcriptional Cross Talk between the Forkhead Transcription Factor Forkhead Box O1A and the Progesterone Receptor Coordinates Cell Cycle Regulation and Differentiation in Human Endometrial Stromal Cells. Mol. Endocrinol. 2007, 21:2334-2349.
72. Talbi S., Hamilton A.E., Vo K.C., Tulac S., Overgaard M.T., Dosiou C., Le Shay N., Nezhat C.N., Kempson R., Lessey B.A., Nayak N.R., Giudice L.C. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology 2006, 147:1097-1121.
73. Tanwar P.S., Lee H.-J., Zhang L., Zukerberg L.R., Taketo M.M., Rueda B.R., Teixeira J.M. Constitutive activation of beta-catenin in uterine stroma and smooth muscle leads to the development of mesenchymal tumors in mice. Biol. Reprod. 2009, 81:545-552.
74. Tanwar P.S., Zhang L., Roberts D.J., Teixeira J.M. Stromal deletion of the apc tumor suppressor in mice triggers development of endometrial cancer. Cancer Res. 2011, 71:1584-1596.
75. Torry D.S., Leavenworth J., Chang M., Maheshwari V., Groesch K., Ball E.R., Torry R.J. Angiogenesis in implantation. J. Assist. Reprod. Genet. 2007, 24:303-315.
76. Tulac S., Nayak N.R., Kao L.C., van Waes M., Huang J., Lobo S., Germeyer A., Lessey B.A., Taylor R.N., Suchanek E., Giudice L.C. Identification, characterization, and regulation of the canonical wnt signaling pathway in human endometrium. J. Clin. Endocrinol. Metab. 2003, 88:3860-3866.
77. Tulac S., Overgaard M.T., Hamilton A.E., Jumbe N.L., Suchanek E., Giudice L.C. Dickkopf-1, an inhibitor of wnt signaling, is regulated by progesterone in human endometrial stromal cells. J. Clin. Endocrinol. Metab. 2006, 91:1453-1461.
78. Vainio S., Heikkila M., Kispert A., Chin N., McMahon A.P. Female development in mammals is regulated by Wnt-4 signalling. Nature 1999, 397:405-409.
79. Van der Horst, P.H., Wang, Y., Vandenput, I., Kühne, L.C., Ewing, P.C., van IJcken, W.F.J., Van der Zee, M., Amant, F., Burger, C.W. Blok, L.J., 2011. Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer, submitted for publication.
80. Wang Y., Hanifi-Moghaddam P., Hanekamp E.E., Kloosterboer H.J., Franken P., Veldscholte J., van Doorn H.C., Ewing P.C., Kim J.J., Grootegoed J.A., Burger C.W., Fodde R., Blok L.J. Progesterone inhibition of Wnt/beta-catenin signaling in normal endometrium and endometrial cancer. Clin. Cancer Res. 2009, 15:5784-5793.
81. Wang Y., van der Zee M., Fodde R., Blok L.J. Wnt/β-catenin and sex hormone signaling in endometrial homeostasis and cancer. Oncotarget 2010, 1:674-684.
82. Wang, Y., Jia, Y., Franken, P.F., Smits, M.J.M., Ewing, P.C., Lydon, J.P., DeMayo, F.J., Burger, C.W., Grootegoed, J.A., Fodde, R. and Blok, L.J. (Accepted 2011) Loss of APC function in mesenchymal cells surrounding the Müllerian duct leads to myometrial defects in adult mice. Mol Cell Endocrinol.
83. Ward E.C., Hoekstra A.V., Blok L.J., Hanifi-Moghaddam P., Lurain J.R., Singh D.K., Buttin B.M., Schink J.C., Kim J.J. The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma. Endocrinology 2008, 149:1942-1950.
84. Wu Y., Kajdacsy-Balla A., Strawn E., Basir Z., Halverson G., Jailwala P., Wang Y., Wang X., Ghosh S., Guo S.-W. Transcriptional characterizations of differences between eutopic and ectopic endometrium. Endocrinology 2006, 147:232-246.
85. Xie H., Tranguch S., Jia X., Zhang H., Das S.K., Dey S.K., Kuo C.J., Wang H. Inactivation of nuclear Wnt-beta-catenin signaling limits blastocyst competency for implantation. Development 2008, 135:717-727.
86. Zanatta A., Rocha A.M., Carvalho F.M., Pereira R.M., Taylor H.S., Motta E.L., Baracat E.C., Serafini P.C. The role of the Hoxa10/HOXA10 gene in the etiology of endometriosis and its related infertility: a review. J. Assist. Reprod. Genet. 2010, 27:701-710.